title: Induction in gastric mucosal prostaglandin and nitric oxide by Helicobacter pylori is dependent on MAPK/ERK-mediated activation of IKK-β and cPLA2: modulatory effect of ghrelin.
abstract: Among the key factors defining the extent of gastric mucosal inflammatory involvement in response to Helicobacter pylori is the excessive generation of prostaglandin (PGE2) and nitric oxide (NO), caused by the overexpression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), and triggered by the activation of mitogen-activated protein kinase (MAPK)/c-Jun N-terminal kinase, p38 and ERK, and nuclear translocation of the cognate transcription factors. In this study, we report on the role of MAPK/ERK in the regulation of H. pylori LPS-induced gastric mucosal expression of COX-2 and iNOS. We show that ERK activation by the LPS leads to phosphorylation of the inhibitory κB kinase-β (IKK-β) and cytosolic phospholipase A2 (cPLA2), and is reflected in the upsurge in NF-κB nuclear translocation, induction in COX-2 and iNOS expression, and up-regulation in cPLA2 activity. The modulatory effect of peptide hormone, ghrelin, on the LPS-induced changes, although associated with further enhancement in ERK, IKK-β, and cPLA2 phosphorylation, was reflected in the suppression of IKK-β and cPLA2 activity through S-nitrosylation. While the effect of ghrelin on S-nitrosylation was susceptible to suppression by the inhibitors of Src/Akt pathway, the inhibition of ERK activation caused the blockage in IKK-β and cPLA2 phosphorylation as well as S-nitrosylation. Taken together, our data show that H. pylori-induced ERK activation plays a critical role in up-regulation of gastric mucosal PGE2 and NO generation at the level of IKK-β and cPLA2 activation, and that ghrelin counters these proinflammatory consequences of the LPS through Src/Akt-dependent S-nitrosylation.
authors.affiliation: Research Center, UMDNJ-NJ Dental School, Room C875, 110 Bergen Street, PO Box 1709, Newark, NJ 07103-2400, USA. slomiabr@umdnj.edu
authors.forename: B L
authors.initials: BL
authors.lastname: Slomiany
authors.forename: A
authors.initials: A
authors.lastname: Slomiany
mesh_terms: D000818:Animals; D015232:Dinoprostone / Q000378:metabolism; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D005753:Gastric Mucosa / Q000382:microbiology / Q000473:pathology*; D054439:Ghrelin / Q000378:metabolism*; D016481:Helicobacter Infections / Q000382:microbiology / Q000503:physiopathology*; D016480:Helicobacter pylori / Q000302:isolation & purification; D051550:I-kappa B Kinase / Q000378:metabolism; D007249:Inflammation / Q000382:microbiology / Q000473:pathology*; D008070:Lipopolysaccharides / Q000633:toxicity; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism; D054510:Phospholipases A2, Cytosolic / Q000378:metabolism; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D051381:Rats; D015854:Up-Regulation; D019061:src-Family Kinases / Q000378:metabolism
chemical_list: D054439:Ghrelin; D008070:Lipopolysaccharides; D009569:Nitric Oxide; D019061:src-Family Kinases; D051057:Proto-Oncogene Proteins c-akt; D051550:I-kappa B Kinase; D048049:Extracellular Signal-Regulated MAP Kinases; D020928:Mitogen-Activated Protein Kinases; D054510:Phospholipases A2, Cytosolic; D015232:Dinoprostone
references.citation: Am J Physiol Heart Circ Physiol. 2010 Sep;299(3):H613-23
references.pmid: 20543082
references.citation: Am J Physiol Heart Circ Physiol. 2008 Jul;295(1):H343-51
references.pmid: 18469150
references.citation: Biochim Biophys Acta. 2000 Oct 31;1488(1-2):124-38
references.pmid: 11080682
references.citation: Endocrinology. 2008 Aug;149(8):4183-92
references.pmid: 18450953
references.citation: Clin Microbiol Rev. 2010 Oct;23(4):713-39
references.pmid: 20930071
references.citation: J Biol Chem. 2008 Feb 8;283(6):3077-3087
references.pmid: 18029351
references.citation: Inflammopharmacology. 2009 Oct;17(5):245-53
references.pmid: 19757089
references.citation: Science. 2005 Dec 23;310(5756):1966-70
references.pmid: 16373578
references.citation: Nat Cell Biol. 2001 Feb;3(2):193-7
references.pmid: 11175752
references.citation: Trends Microbiol. 2010 Nov;18(11):479-86
references.pmid: 20863705
references.citation: PLoS One. 2012;7(1):e29920
references.pmid: 22238675
references.citation: J Biol Chem. 2001 Dec 28;276(52):48693-701
references.pmid: 11668179
references.citation: ISRN Gastroenterol. 2011;2011:308727
references.pmid: 21991502
references.citation: J Biol Chem. 2004 Dec 17;279(51):53196-204
references.pmid: 15485865
references.citation: Inflammopharmacology. 2013 Feb;21(1):67-78
references.pmid: 22669511
references.citation: PLoS One. 2009;4(3):e4686
references.pmid: 19262695
references.citation: Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):8945-50
references.pmid: 15184672
references.citation: J Immunol. 2006 Dec 1;177(11):8111-22
references.pmid: 17114486
references.citation: Adv Exp Med Biol. 1997;407:249-53
references.pmid: 9321960
references.citation: J Biol Chem. 2007 May 11;282(19):13977-83
references.pmid: 17376775
references.citation: Am J Physiol Lung Cell Mol Physiol. 2007 May;292(5):L1219-26
references.pmid: 17220375
references.citation: Bioorg Med Chem Lett. 2011 Jan 1;21(1):577-83
references.pmid: 21078555
references.citation: Inflammopharmacology. 2011 Aug;19(4):197-204
references.pmid: 21516493
references.citation: Cardiovasc Res. 2009 Jun 1;82(3):522-31
references.pmid: 19233864
references.citation: Carcinogenesis. 2005 Sep;26(9):1520-6
references.pmid: 15878913
references.citation: J Immunol. 2006 Jan 1;176(1):580-8
references.pmid: 16365453
references.citation: Nat Rev Immunol. 2009 Oct;9(10):692-703
references.pmid: 19859064
references.citation: Kidney Int. 2007 Feb;71(4):290-7
references.pmid: 17200681
references.citation: Nat Rev Immunol. 2004 Jul;4(7):499-511
references.pmid: 15229469
references.citation: J Biol Chem. 2003 May 9;278(19):17368-78
references.pmid: 12606553
references.citation: IUBMB Life. 2006 Apr;58(4):217-23
references.pmid: 16754300
references.citation: Int J Med Microbiol. 2003 Dec;293(6):403-12
references.pmid: 14760971
references.citation: Mol Endocrinol. 2009 Jan;23(1):86-99
references.pmid: 18945810
references.citation: Arch Biochem Biophys. 2007 Apr 1;460(1):67-74
references.pmid: 17313938
references.citation: Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62
references.pmid: 17183360